BIO-TIC launches three major bio-Roadmaps to tackle innovation hurdles in industrial biotechnology in Europe
- The market roadmap gives an overview of the current markets for a selection of five industrial biotechnology business cases for Europe and market projections extending to 2030. In order to identify potential product segments and overcome market barriers, “it is important that the voice of the bio-based industry is heard,” says Anna Saarentaus from Pöyry and leader of the market roadmap.
- The technological roadmap aims to gain insight into the R&D‑related hurdles that are impeding the full realization of Europe’s industrial biotechnology market potential in 2030. In addition, the roadmap seeks to set priorities in terms of R&D and other actions to overcome the R&D hurdles. “Bioconversion and feedstock supply are the areas where most efforts in terms of R&D should be taken,” argues Elsbeth Roelofs from TNO and leader of the technological roadmap.
- The non-technological roadmap aims to identify regulatory and non-technological hurdles that may inhibit industrial biotechnology innovation towards identified market opportunities in the market roadmap. Dirk Carrez, leader of the non-technological roadmap, Clever Consult, says: “Innovation will only be stimulated if a correct regulatory and policy framework is in place. This is why the identification of regulatory and non-technological hurdles that may inhibit innovation in the area of industrial Biotechnology, and possible solutions for key market entry barriers are an important part of the BIO-TIC project”.